Clinical Trial Detail

NCT ID NCT01633541
Title Chemotherapy AND Bcl-xL Inhibitor (AT-101) For Organ Preservation In Adults With Advanced Laryngeal Cancer
Recruitment Active, not recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors University of Michigan Cancer Center
Indications

laryngeal squamous cell carcinoma

Therapies

AT-101

Carboplatin

Cisplatin

Docetaxel

Age Groups: adult

No variant requirements are available.